Harbin Medisan Pharmaceutical Co., Ltd.
SZSE:002900.SZ
12.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 991.162 | 1,202.646 | 529.833 | 661.448 | 471.492 | 451.686 | 354.658 | 128.849 | 80.853 | 93.21 | 85.87 | 80.249 |
| Short Term Investments
| 57.754 | 91.252 | 581.676 | 360.791 | 696.725 | 104.909 | 649 | -4.076 | 0 | 0 | -3.499 | 0 |
| Cash and Short Term Investments
| 1,048.916 | 1,293.899 | 1,111.509 | 1,022.239 | 1,168.216 | 556.595 | 354.658 | 128.849 | 80.853 | 93.21 | 85.87 | 80.249 |
| Net Receivables
| 99.465 | 124.596 | 132.984 | 157.853 | 206.336 | 0 | 0 | 89.311 | 80.033 | 95.687 | 86.222 | 67.467 |
| Inventory
| 208.787 | 161.16 | 156.548 | 186.512 | 214.335 | 183.94 | 147.715 | 89.141 | 104.534 | 105.389 | 100.746 | 98.399 |
| Other Current Assets
| 77.543 | 44.005 | 26.153 | 77.216 | 96.704 | 327.237 | 664.367 | 36.587 | 27.412 | 10.797 | 35.24 | 51.644 |
| Total Current Assets
| 1,436.439 | 1,623.659 | 1,427.194 | 1,440.16 | 1,685.592 | 1,645.211 | 1,358.989 | 339.752 | 292.832 | 305.084 | 308.078 | 297.759 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,081.587 | 882.449 | 925.345 | 867.29 | 806.691 | 725.711 | 721.716 | 722.601 | 671.579 | 571.019 | 456.498 | 332.298 |
| Goodwill
| 1.34 | 0.5 | 9.436 | 9.436 | 9.436 | 9.436 | 9.436 | 9.436 | 9.436 | 10.787 | 10.787 | 10.287 |
| Intangible Assets
| 141.209 | 71.67 | 62.504 | 66.417 | 70.053 | 72.567 | 50.639 | 51.765 | 52.676 | 53.729 | 54.633 | 62.61 |
| Goodwill and Intangible Assets
| 142.549 | 72.17 | 71.94 | 75.853 | 79.489 | 82.003 | 60.075 | 61.201 | 62.112 | 64.516 | 65.42 | 72.897 |
| Long Term Investments
| 651.234 | 555.614 | 22.826 | -345.876 | -673.322 | -72.01 | 20 | 8.149 | 4.074 | 4.074 | 7.572 | 3.21 |
| Tax Assets
| 23.08 | 23.813 | 25.842 | 23.888 | 21.062 | 21.562 | 19.925 | 20.485 | 20.591 | 23.626 | 20.978 | 13.702 |
| Other Non-Current Assets
| 108.096 | 119.083 | 592.369 | 421.446 | 752.611 | 111.079 | 3.042 | 14 | 1.737 | 2.144 | -0.794 | -0.86 |
| Total Non-Current Assets
| 2,006.545 | 1,653.129 | 1,638.323 | 1,042.601 | 986.532 | 868.344 | 824.757 | 826.436 | 760.093 | 665.378 | 549.674 | 421.248 |
| Total Assets
| 3,442.984 | 3,276.788 | 3,065.517 | 2,482.761 | 2,672.124 | 2,513.555 | 2,183.746 | 1,166.188 | 1,052.924 | 970.462 | 857.752 | 719.007 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 182.133 | 120.839 | 105.162 | 90.011 | 96.365 | 76.81 | 77.98 | 97.036 | 99.294 | 128.382 | 125.46 | 109.444 |
| Short Term Debt
| 275.267 | 230.395 | 270.28 | 269.782 | 180 | 58 | 0 | 106 | 90 | 107 | 127 | 72 |
| Tax Payables
| 3.076 | 12.153 | 11.153 | 10.765 | 31.85 | 19.061 | 46.141 | 26.956 | 13.84 | 8.806 | 42.64 | 33.049 |
| Deferred Revenue
| 43.247 | 54.792 | 154.128 | 226.974 | 350.239 | 19.061 | 43.874 | 48.216 | 28.551 | 23.463 | 144.729 | 105.747 |
| Other Current Liabilities
| 341.311 | 234.347 | 128.955 | 198.86 | 415.08 | 293.319 | 98.629 | 41.961 | 4.175 | 28.306 | -15.318 | 108.294 |
| Total Current Liabilities
| 845.034 | 597.734 | 536.614 | 588.84 | 723.295 | 447.191 | 266.624 | 271.953 | 235.86 | 272.493 | 424.512 | 322.788 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 238.159 | 422.93 | 212.868 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 79.028 | 83.865 | 88.956 | 88.712 | 84.896 | 90.279 | 82.173 | 86.054 | 89.075 | 88.781 | 68.076 | 53.452 |
| Deferred Tax Liabilities Non-Current
| 132.539 | 120.273 | 110.605 | 13.632 | 12.248 | 6.313 | 0.002 | 0.008 | 0.018 | 0.028 | 0.038 | 0.048 |
| Other Non-Current Liabilities
| 0 | -0.672 | 0 | 99.58 | 0 | 0 | 0 | 0.008 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 449.726 | 627.067 | 412.43 | 102.343 | 97.144 | 96.592 | 82.176 | 86.062 | 89.093 | 88.809 | 68.114 | 53.5 |
| Total Liabilities
| 1,294.76 | 1,224.801 | 949.044 | 691.183 | 820.439 | 543.783 | 348.8 | 358.014 | 324.953 | 361.303 | 492.626 | 376.288 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 316.39 | 316.6 | 316.6 | 316.6 | 316.6 | 316.6 | 211.067 | 158.3 | 158.3 | 158.3 | 150 | 10.4 |
| Retained Earnings
| 612.933 | 570.719 | 639.64 | 341.231 | 411.102 | 462.982 | 391.898 | 306.668 | 244.341 | 142.826 | 11.308 | 310.265 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 162.452 | 192.289 | 164.529 | 152.074 | 128.903 | 87.755 | 46.331 | 28.455 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,211.17 | 995.052 | 952.92 | 952.92 | 952.92 | 1,167.596 | 1,144.227 | 296.875 | 325.33 | 308.033 | 203.818 | 15.2 |
| Total Shareholders Equity
| 2,140.492 | 2,040.671 | 2,101.449 | 1,775.281 | 1,832.696 | 1,947.459 | 1,834.947 | 808.174 | 727.971 | 609.16 | 365.126 | 335.865 |
| Total Equity
| 2,148.224 | 2,051.987 | 2,116.473 | 1,791.578 | 1,851.684 | 1,969.772 | 1,834.947 | 808.174 | 727.971 | 609.16 | 365.126 | 342.719 |
| Total Liabilities & Shareholders Equity
| 3,442.984 | 3,276.788 | 3,065.517 | 2,482.761 | 2,672.124 | 2,513.555 | 2,183.746 | 1,166.188 | 1,052.924 | 970.462 | 857.752 | 719.007 |